GeneReg 2025
GENETIC POLYMORPHISMS IN THE VDR GENE AND THEIR INFLUENCE ON NATALIZUMAB RESPONSE IN MULTIPLE SCLEROSIS PATIENTS
BCTRIMS 2024
FCGR2A rs1801274 polymorphism is associated with response to natalizumab in multiple sclerosis patients
FRONTIERS 2024
FCGR2A variant rs1801274 as a Pharmacogenetic Predictor of Natalizumab Therapeutic Failure in Multiple Sclerosis Patients
FRONTIERS 2024
TLR4 genetic variants in the interface between gut-brain axis and Natalizumab response in Multiple Sclerosis patients.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper